Proxima CRO

Great Place to Work®

Proxima Clinical Research has been recognized as a Great Place to Work® certified company in 2021.

Feedback from team members: "We are proud to make a difference in the lives and businesses of MedTech and Biotech inventors and emerging companies."

Learn more

Proxima works with emerging biotech and medical device companies across all phases of development.

As a contract research organization, we organize our team in two distinct areas: early stage advisory consulting and all-inclusive clinical trial services. The service you need. The speed you want. The attention you deserve.

Client News

Puzzle Medical Receives U.S. Food and Drug Administration (FDA) Breakthrough Device Designation

Puzzle Medical's focus is to improve patient quality of life and reduce the global economic burden related to heart failure. Puzzle Medical is developing a proprietary transcatheter heart pump associated with minimal trauma to the blood components, allowing for safe and efficient heart support without open-heart surgery.

Learn More

Knoweldge Base

What is a consent agreement?

Got questions? We've got answers. Head over to our Knowledge Base and learn more.

Got questions?

PODCASTS

Inventing Tomorrow by Proxima. Launching Soon!

Hear from our innovators:

“Proxima has been such a wonderful help every step of the way. Everyone is truly great to work with.”

Karen Wells

Junior Project Engineer

Proxima was instrumental to our success in getting breakthrough device designation for our product! The team was very knowledgeable and responsive and set us up for success. They made the FDA process easy to go through and prepared us for future interactions with FDA.

Jade Doucet-Martineau

Co-Founder

"Proxima staff understood the needs of our company and took a vested interest in supporting our clinical trial’s aggressive timeline while safeguarding our goals and objectives. Proxima has been a true partner for our early stage medical device startup!"

Zaffer Syed

Sr. VP, Marketing & Clinical Development

Finally, a next-gen CRO

Dedicated to the New Class of Rising Stars in Drugs, Medical Devices, and Diagnostics